Back

argenx SE

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 28 may 2019 - 07:00
  • Statutory name argenx SE
  • Title argenx announces publication of efgartigimod Phase 2 myasthenia gravis trial results in Neurology

Related downloads

201905280000000002_argenx announces publication of efgartigimod Phase 2 myasthenia gravis trial results in Neurology.pdf

Date last update: 18 June 2019

Share information

Share on: Share this